Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds
Bioorganic Chemistry · 2024-06 · 147 · 107355
DOI: 10.1016/j.bioorg.2024.107355 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2024-06. Verfasst von Yasaman Tamaddon-Abibigloo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicinal Chemistry, School of pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz Uni…. Hauptthemen laut MEDLINE: Acetylcholinesterase, Alzheimer Disease, Aniline Compounds, Butyrylcholinesterase. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Tabriz University of Medical Sciences.
Themen: Demenz
Abstract (Originalsprache)
Multi target directed ligands (MTDLs) are one of the promising tools for treatment of complex disease like Alzheimer's disease (AD). In this study, using rational design, we synthesized new 15 hybrids of the s-triazine, isatin and aniline derivatives as anti- AD compounds. The design was as way as that new compounds could had anti cholinesterase (ChE), antioxidant and biometal chelation ability. In vitro biological evaluation against ChE enzymes showed that these molecules were excellent inhibitors with IC50 values ranging from 0.2 nM to 734.5 nM for acetylcholinesterase (AChE), and 0.02 μM to 1.92 μM for butyrylcholinesterase (BChE). Among these compounds, 8 l with IC50 AChE = 0.7 nM, IC50 BChE = 0.09 μM and 8n with IC50 AChE = 0.2 nM, IC50 BChE = 0.03 μM were the most potent compounds. In silico studies showed that these molecules had key and effective interactions with the corresponding enzymes residues. The molecules with hydroxyl group on aniline moiety had also good antioxidant activity with EC50 values ranging from 64.2 μM to 103.6 μM. The UV-Vis spectroscopy study revealed that molecule 8n was also able to chelate biometals such as Zn2+, Cu2+and Fe2+ properly. It was concluded that these molecules could be excellent lead compounds for future studies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicinal Chemistry, School of pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.
- Department of Medicinal Chemistry, School of pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran; Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran; Faculty of Pharmacy, Near E…
- Department of Medicinal Chemistry, School of Pharmacy, Ardabil University of Medical Sciences, Ardabil, Iran.
- Department of Medicinal Chemistry, School of pharmacy, Tabriz University of Medical Sciences, Tabriz, Iran. Electronic address: shahbazi_j@tbzmed.ac.ir.
Förderung
- Tabriz University of Medical Sciences
Zitieren
APA
Tamaddon-Abibigloo, Y., Dastmalchi, S., Razzaghi-Asl, N., & Shahbazi Mojarrad, J. (2024). Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds. Bioorganic Chemistry, 147, 107355. https://doi.org/10.1016/j.bioorg.2024.107355
Vancouver
Tamaddon-Abibigloo Y, Dastmalchi S, Razzaghi-Asl N, Shahbazi Mojarrad J. Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds. Bioorganic Chemistry. 2024;147:107355. doi:10.1016/j.bioorg.2024.107355
BibTeX
@article{TamaddonAbibigloo2024,
author = {Tamaddon-Abibigloo, Yasaman and Dastmalchi, Siavoush and Razzaghi-Asl, Nima and Shahbazi Mojarrad, Javid},
title = {Design, synthesis, in vitro and in silico evaluations of new isatin-triazine- aniline hybrids as potent anti- Alzheimer multi-target directed lead compounds},
journal = {Bioorganic Chemistry},
year = {2024},
volume = {147},
pages = {107355},
doi = {10.1016/j.bioorg.2024.107355}
}
EUVIMED